Carregant...
Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics
Genetic studies have identified variants in the LRRK2 gene as important components of Parkinson’s disease (PD) pathobiology. Biochemical and emergent biomarker studies have coalesced around LRRK2 hyperactivation in disease. Therapeutics that diminish LRRK2 activity, either with small molecule kinase...
Guardat en:
| Publicat a: | Front Neurosci |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7438883/ https://ncbi.nlm.nih.gov/pubmed/32903744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2020.00807 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|